Form 4 for GILD Gilead Sciences
Accepted 2022-11-10 00:00:00 ET · period of report 2022-11-09 · accession 0001127602-22-025292 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-10 | 2022-11-09 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $63.91 | +6,416 | 34.7K | +23% | +$410.0K |
| D | 2022-11-10 | 2022-11-09 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | S - Sale+OE | $83.50 | -6,416 | 28.3K | -18% | -$535.7K |
| D | 2022-11-10 | 2022-11-09 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $0.00 | -6,416 | 10.7K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-09 | M | A | 6,416 | $63.91 | 34,749 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-09 | S | D | 6,416 | $83.50 | 28,333 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2022-11-09 | M | D | 6,416 | $0.00 | 10,694 | D | $63.91 · — to 2031-03-10 | 6,416 Common Stock | (F1) The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |